Novartis and NHS Alliance collaborate on commissioning guides

July 14, 2009
Sales and Marketing NHS, Novartis, PBC

Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …

World class commissioning: 5 ways pharma can get involved

July 13, 2009
Sales and Marketing NHS, commissioning, healthcare, marketing

The NHS has set its sights unambiguously on achieving World Class Commissioning. After years of being internally-focused, the health service …

Virgo launches pharma communications blog

July 13, 2009
Medical Communications Virgo, digi

 Specialist healthcare PR agency Virgo Health has launched a blog with the aim of stimulating debate over the future of …

Chiesi breaks ground on new R&D headquarters in Palma

July 13, 2009
Research and Development Chiesi, Europe, Italy

Construction of Chiesi's new 70 million euro centre for research and development has begun in Parma, Italy. The Italian company …

Contract research sector: news in brief

July 13, 2009
Research and Development Veeda

Pharmafocus presents a round-up of developments in the contract research sector, including Icon's acquisition of biomarker specialist Veeda, layoffs at …

AstraZeneca’s AZD3480 progresses in ADHD

July 11, 2009
Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca

 AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …

Adventis Health launches brand competition

July 10, 2009
Medical Communications Adventis

Adventis Health has celebrated its official launch as a fully integrated healthcare communications agency. To mark this milestone, the company …

Pfizer to set up new lab in Ireland

July 10, 2009
Manufacturing and Production Europe, Ireland, Pfizer

Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …

Biopharma company contributes to GSK’s ‘patent pool’

July 10, 2009
Research and Development Orphan

Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …

NICE to reconsider GSK’s Tyverb

July 9, 2009
Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …

Victoza launched in UK

July 9, 2009
Sales and Marketing Victoza, diabetes

Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …

New clients for Cegedim Dendrite

July 9, 2009
Medical Communications Cegedim

Cegedim Dendrite, a leading provider of CRM software and healthcare data to the pharma industry, has announced significant growth over …

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009
Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009
Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …

Europe launches pharma competition crackdown

July 8, 2009
Research and Development Europe, generics

The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …

Eisai's new European HQ in Hatfield, Hertfordshire

Eisai opens new European HQ in the UK

July 8, 2009
Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ

Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …

UCB's new biologics research centre in Slough

UCB opens new UK biologics research centre

July 8, 2009
Research and Development UCB

 UCB has officially opened its new biologics research centre in the UK, representing an investment of £25 million for the …

GMP violations at Indian CMO hit UK generics makers

July 8, 2009
Manufacturing and Production Asia, India

Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …

Sanofi moves to quell Lantus safety concerns

July 7, 2009
Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes

Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …

The Gateway to Local Adoption Series

Latest content